This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Mayo Foundation for Medical Education and Research, University Health Network. Active years: 2014.
Company Filing History:
1 out of 1,808 
1 out of 311 
Years Active: 2014
Title: Rodger E Tiedemann: Innovator in Cyclin D Polypeptide Inhibition
Introduction
Rodger E Tiedemann is a notable inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of medical research, particularly in the area of cyclin D polypeptide inhibition. His work has implications for identifying and treating conditions related to cyclin D activity.
Latest Patents
Rodger E Tiedemann holds 1 patent for his invention titled "Inhibiting Cyclin D Polypeptides." This patent involves methods and materials related to inhibiting cyclin D polypeptide activity. The document outlines methods to identify mammals or cells that require cyclin D polypeptide inhibition and provides ways to administer agents capable of inhibiting this activity.
Career Highlights
Throughout his career, Tiedemann has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and the University Health Network. His experience in these institutions has allowed him to collaborate with leading experts in the field.
Collaborations
Some of his notable coworkers include Aaron David Schimmer and Alexander Keith Stewart. Their collective efforts have contributed to advancements in medical research and innovation.
Conclusion
Rodger E Tiedemann's work in inhibiting cyclin D polypeptides showcases his commitment to advancing medical science. His contributions are vital for future research and potential therapeutic applications.